Clinical trial
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or…
NCT00308269 · Endocyte, Industry · Completed
Key facts
| NCT number | NCT00308269 |
|---|---|
| Title | Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) |
| Official title | Protocol EC-FV-01: A Phase 1 Study of EC145 Administered in Weeks 1 and 3 of a 4-Week Cycle |
| Lead sponsor | Endocyte, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | Vintafolide IV Bolus, Vintafolide IV Infusion |
| Enrollment | 32 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Mar 29, 2006 |
| Last update posted | Dec 19, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: